The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects.
暂无分享,去创建一个
T. Baillie | M. Davis | C. Matthews | K. Lasseter | E. Woolf | D. Musson | G. Doss | J. Schwartz | R. Mazenko | D. Cui | L. Geer | K. Vyas | A. Porras | R. Halpin | R. A. Halpin